Research Project · Cancer immunotherapy

CRI Technology Impact Award

www.cancerresearch.org (opens in a new tab)Catalog updated

Deadline Letter of intent
Amount
$600,000
Program type
Research Project
Field
Cancer immunotherapy
Eligible career stages
Not listed

About this program

The Cancer Research Institute’s Technology Impact Award provides seed funding of up to $600,000 over 2–4 years, plus up to 10% indirect costs, for high-risk, high-reward technologies with potential to transform cancer immunotherapy. The program supports early-stage, pre-development innovations—not refinement of existing technologies or clinical trials—including novel computational, profiling, visualization, culture, and therapeutic platforms. Applicants must hold a tenure-track position at a nonprofit research center or institution; collaboration between technology developers and clinical cancer immunologists, including co-PI applications, is encouraged. Letters of intent are due November 16, 2026, and invited full proposals are due March 12, 2027.

In FundFit

FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.

Ask for a demo of this program The form opens already filled in.

Full eligibility

Source announcement

Similar programs